Tag Archives: Keep

Insurers, drug price advocacy groups pressure Congress to keep Medicare discounts

Congressional leaders must resist the drug lobby’s efforts to roll back a discount for prescription drugs that seniors purchase on Medicare, according to a letter from 16 groups that include top drug pricing reform, insurer, and hospital groups. The groups sent the letter late Tuesday to House and Senate leadership. It calls for Congress to… Read More »